Ekso Bionics Holdings, Inc. Sample Contracts
UNDERWRITER COMMON STOCK PURCHASE WARRANT EKSO BIONICS HOLDINGS, INC.Security Agreement • February 11th, 2021 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
THIS UNDERWRITER COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 8, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock, as defined in Section 1 herein. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to the Underwriting Agreement.
COMMON STOCK PURCHASE WARRANT EKSO BIONICS HOLDINGS, INC.Common Stock Purchase Warrant • March 17th, 2025 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after 5:00 p.m. (New York City Time) on the Stockholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five (5) year anniversary of the Stockholder Approval Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Ekso Bionics Holdings, Inc, a Nevada corporation (the “Company”), up to ______________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 20th, 2019 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 18, 2019, between Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 10th, 2020 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 7, 2020, between Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Ekso Bionics Holdings, Inc. 3,902,440 Shares of Common Stock (par value $0.001 per share) Amended and Restated Underwriting AgreementUnderwriting Agreement • February 11th, 2021 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
Ekso Bionics Holdings, Inc., a company incorporated under the laws of the State of Nevada (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 3,902,440 shares of its common stock, par value $0.001 per share (the “Shares”). The 3,902,440 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 585,366 Shares as provided in Section 2 (the “Optional Shares”). The Firm Shares and, if and to the extent such option is exercised, the Optional Shares, are collectively called the “Offered Shares.” H.C. Wainwright & Co., LLC (“Wainwright”) has agreed to act as representative of the several Underwriters (in such capacity, the “Representative”) in connection with the offering and sale of the Offered Shares. To the extent there are no additional underwriters listed on Schedule A, the term “Representative” as used herein
EKSO BIONICS HOLDINGS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • August 21st, 2018 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
Ekso Bionics Holdings, Inc. a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
SERIES B COMMON STOCK PURCHASE WARRANT EKSO BIONICS HOLDINGS, INC.Warrant Agreement • September 3rd, 2024 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
THIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ____1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Ekso Bionics Holdings, Inc, a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PRE-FUNDED COMMON STOCK PURCHASE WARRANT EKSO BIONICS HOLDINGS, INC.Pre-Funded Common Stock Purchase Warrant • September 3rd, 2024 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Ekso Bionics Holdings, Inc, a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
AT THE MARKET OFFERING AGREEMENTAt the Market Offering Agreement • October 9th, 2020 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
Ekso Bionics Holdings, Inc., a corporation organized under the laws the State of Nevada (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:
3,750,000 SHARES EKSO BIONICS HOLDINGS, INC. COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • August 9th, 2016 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
SHARES OF COMMON STOCK AND _____________PRE-FUNDED WARRANTS (EXERCISABLE FOR ____ SHARES OF COMMON STOCK) OF EKSO BIONICS HOLDINGS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • July 29th, 2024 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
The undersigned, Ekso Bionics Holdings, Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of Ekso Bionics Holdings, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Craig-Hallum Capital Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 16th, 2024 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of January 10, 2024, between Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Ekso Bionics Holdings, Inc.Placement Agent Common Stock Purchase Warrant • December 20th, 2019 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on December 18, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement agreement, dated as of December 17, 2019, by and between the Company and H.C. Wainwright & Co., LLC (the “Engagement Letter”).
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Ekso Bionics Holdings, Inc.Placement Agent Agreement • June 10th, 2020 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec
THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on June 7, 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement letter, dated as of June 5, 2020, by and between the Company and H.C. Wainwright & Co., LLC (the “Engagement Letter”).
COMMON STOCK PURCHASE WARRANT Ekso Bionics Holdings, Inc.Common Stock Purchase Agreement • June 10th, 2020 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PLACEMENT AGENCY AGREEMENT April 2, 2017Placement Agency Agreement • April 5th, 2017 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
COMMON STOCK PURCHASE WARRANT ekso bionics holdings, inc.Common Stock Purchase Warrant • December 24th, 2015 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from EKSO Bionics Holdings, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
FORM OF Registration Rights AgreementRegistration Rights Agreement • January 23rd, 2014 • Ekso Bionics Holdings, Inc. • Wholesale-medical, dental & hospital equipment & supplies • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into effective as of _______________ ___, 2014, between Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), the persons who have executed omnibus or counterpart signature page(s) hereto (each, a “Purchaser” and collectively, the “Purchasers,” which terms, for avoidance of doubt, include all persons who purchased Bridge Notes (as defined below) and/or Units (as defined below)), and the persons or entities identified on Schedule 1 hereto holding Bridge Placement Agent Warrants, Placement Agent Warrants (each as defined below) or Lender Warrants (collectively, the “Other Holders”).
SERIES B COMMON STOCK PURCHASE WARRANT EKSO BIONICS HOLDINGS, INC.Warrant Agreement • August 28th, 2024 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
THIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ____ 1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Ekso Bionics Holdings, Inc, a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among EKSO BIONICS HOLDINGS, INC. (formerly PN Med Group Inc.) EKSO ACQUISITION CORP., EKSO BIONICS, INC. AND WITH RESPECT TO SECTION 6.3(F), Nathan Harding, as Indemnification Representative January 15,...Merger Agreement • January 23rd, 2014 • Ekso Bionics Holdings, Inc. • Wholesale-medical, dental & hospital equipment & supplies • Delaware
SUBSCRIPTION AGREEMENTSubscription Agreement • January 23rd, 2014 • Ekso Bionics Holdings, Inc. • Wholesale-medical, dental & hospital equipment & supplies • New York
This Subscription Agreement (this “Agreement”) has been executed by the subscriber set forth on the signature page hereof (the “Subscriber”) in connection with the private placement offering (the “Offering”) of a minimum of $12,000,000 (the “Minimum Offering”) and a maximum of $20,000,000 (the “Maximum Offering”) of Units of securities (the “Units”), plus up to an additional $5,000,000 of Units to cover over-allotments, issued by PN Med Group Inc., a Nevada corporation (the “Company”), at a purchase price of $1.00 per Unit (the “Purchase Price”). Each Unit consists of (i) one share of the Company’s common stock, par value $0.001 per share (“Common Stock”), and (ii) a warrant, substantially in the form of Exhibit A hereto (the “Warrant”), representing the right to purchase one share of Common Stock, exercisable from issuance until five (5) years after the initial Closing of the Offering at an exercise price of $2.00 per share. This subscription is being submitted to you in accordance wi
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • January 23rd, 2014 • Ekso Bionics Holdings, Inc. • Wholesale-medical, dental & hospital equipment & supplies • New York
This Placement Agency Agreement (“Agreement”) sets forth the terms upon which Gottbetter Capital Markets, LLC, a registered broker-dealer and member of the Financial Industry Regulatory Authority (“FINRA”), (hereinafter referred to as the “Placement Agent” or “Markets”), shall be engaged by PN Med Group Inc. (to be renamed EKSO Bionics Holdings, Inc.), a publicly traded corporation duly organized under the laws of the State of Nevada, (hereinafter referred to as the “Company” or “Ekso”), to act as an exclusive Placement Agent in connection with the private placement (hereinafter referred to as the “Offering”) of units (the “Units”) of securities of the Company, as more fully described below. The initial closing of the Offering will be conditioned upon the receipt of subscriptions for the Minimum Amount (as defined below) and the consummation of a reverse triangular merger (the “Merger”) between a subsidiary of the Company and Ekso Bionics, Inc., a Delaware corporation (“Ekso”) and cert
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 25th, 2017 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec
This Registration Rights Agreement (this "Agreement") is made and entered into as of July 19, 2017, by and among Ekso Bionics Holdings, Inc., a Nevada corporation (the "Company"), and the several purchasers signatory hereto (each a "Purchaser" and collectively, the "Purchasers").
EMPLOYMENT AGREEMENTEmployment Agreement • March 19th, 2015 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • California
THIS EMPLOYMENT AGREEMENT (the “Agreement”), made as of this 19th day of March, 2015, is entered into by Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), and Thomas Looby, residing at 3485 Camellia Lane, Suwanee, Georgia 30024 (the “Executive”).
PURCHASE AGREEMENTPurchase Agreement • July 25th, 2017 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
This Purchase Agreement (this "Agreement"), dated as of July 19, 2017, is entered into by and between Ekso Bionics Holdings, Inc., a Nevada corporation (including any of its successors by merger, acquisition, reorganization, conversion or otherwise, the "Company"), and the Persons set forth on Schedule I hereto (the "Purchasers" and each, a "Purchaser").
WARRANT AGENT AGREEMENTWarrant Agent Agreement • October 23rd, 2014 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
THIS WARRANT AGENT AGREEMENT, dated October 21, 2014 (the “Agreement”), is entered into by and between EDI Financial, Inc. (the “Warrant Agent”) and Ekso Bionics Holdings, Inc. (the “Company”).
INVESTOR RIGHTS AGREEMENT DATED AS OF [•], 2026 BETWEEN CHRONOSCALE CORPORATION AND APLD CHRONOSCALE HOLDCO LLCInvestor Rights Agreement • February 17th, 2026 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • Nevada
This Investor Rights Agreement (this “Agreement”) is entered into as of [•], 2026 (the “Effective Date”) by and between ChronoScale Corporation, a Nevada corporation (the “Company”), and APLD ChronoScale Holdco LLC, a Delaware limited liability company (the “Investor”), as the sole APLD Investor as of the date hereof. Certain terms used in this Agreement are defined in Section 1.1.
EKSO BIONICS HOLDINGS, INC. 6,666,667 Shares of Common Stock Warrants to Purchase 6,666,667 Shares of Common Stock (par value $0.001 per share) Underwriting AgreementUnderwriting Agreement • May 24th, 2019 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
Ekso Bionics Holdings, Inc. a Nevada corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) (i) an aggregate of 6,666,667 shares (the “Shares”) of its common stock, par value $0.001 per share (the “Common Stock”) and (ii) warrants, substantially in the form of Annex A hereto, to purchase an aggregate of 6,666,667 shares of Common Stock with an exercise price equal to $2.00, per share (the “Warrants” and together with the Shares, the “Securities”). Cantor Fitzgerald & Co. (“Cantor”) and SunTrust Robinson Humphrey, Inc. (“SunTrust”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Securities. To the extent there are no additional underwriters listed on Schedule A, the term “Representatives” as used herein shall mean Cantor and SunTrust, as Underwriters, and the term “Underwriters” shall mean either the singular or
CONTRIBUTION AND EXCHANGE AGREEMENT BY AND AMONG EKSO BIONICS HOLDINGS, INC., APLD CHRONOSCALE HOLDCO LLC, APLD INTERMEDIATE HOLDCO LLC AND APPLIED DIGITAL CLOUD CORPORATIONContribution and Exchange Agreement • February 17th, 2026 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • Nevada
This CONTRIBUTION AND EXCHANGE AGREEMENT (this “Agreement”) dated as of February 14, 2026, is entered into by and among Ekso Bionics Holdings, Inc., a Nevada corporation (“Issuer”), APLD Intermediate HoldCo LLC, a Delaware limited liability company (“APLD Intermediate”), APLD ChronoScale HoldCo LLC, a Delaware limited liability company and wholly owned subsidiary of APLD Intermediate (“Contributor”), and Applied Digital Cloud Corporation, a Nevada corporation and wholly owned subsidiary of APLD Intermediate (“Cloud”). Certain terms used in this Agreement are defined in Section 1.1.
EKSO BIONICS HOLDINGS, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • November 7th, 2025 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • California
This Change in Control and Severance Agreement (the “Agreement”) is made between Ekso Bionics Holdings, Inc. (the “Company”) and Jason C. Jones (the “Executive”).
INDEMNIFICATION SHARES ESCROW AGREEMENTIndemnification Agreement • January 23rd, 2014 • Ekso Bionics Holdings, Inc. • Wholesale-medical, dental & hospital equipment & supplies • New York
This Indemnification Shares Escrow Agreement (this “Agreement”) is entered into as of January 15, 2014 by and among Ekso Bionics Holdings, Inc. (f/k/a PN Med Group Inc.), a Nevada corporation (the “Parent”), Nathan Harding, a California resident (the “Indemnification Representative”), and Gottbetter & Partners, LLP, as escrow agent (the “Escrow Agent”). Capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the Merger Agreement (as defined below).
3,100,000 SHARES OF COMMON STOCK, PRE-FUNDED WARRANTS (EXERCISABLE FOR 2,900,000 SHARES OF COMMON STOCK) SERIES A WARRANTS (EXERCISABLE FOR 6,000,000 SHARES OF COMMON STOCK) AND SERIES B WARRANTS (EXERCISABLE FOR 6,000,000 SHARES OF COMMON STOCK) OF...Underwriting Agreement • September 3rd, 2024 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec • New York
The undersigned, Ekso Bionics Holdings, Inc., a company incorporated under the laws of Nevada (collectively with its subsidiaries, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries of Ekso Bionics Holdings, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Craig-Hallum Capital Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
EXCLUSIVE LICENSE AGREEMENT FOR: MECHANISM TO ENABLE NORMAL GAIT DESPITE LEG INJURIES, DECREASING OXYGEN CONSUMPTION BY USE OF A LOAD-CARRYING EXOSKELETON, UNDER-ACTUATED TRANSFEMORAL PROSTHETIC KNEE, AND CONTROLLING THE SWINGING LEG OF AN EXOSKELETON...Exclusive License Agreement • January 23rd, 2014 • Ekso Bionics Holdings, Inc. • Wholesale-medical, dental & hospital equipment & supplies • California
This license agreement (“AGREEMENT”) is entered into as of the date that this AGREEMENT is fully executed by both parties (“EFFECTIVE DATE”), by and between The Regents of the University of California, a California corporation, having its statewide administrative offices at 1111 Franklin Street, 12th Floor, Oakland, California 94607-5200 acting through its Office of Technology Licensing, at the University of California, Berkeley, having its administrative office at 2150 Shattuck Avenue, Suite 510, Berkeley, CA 94720-1620 (“REGENTS”), and Berkeley ExoTech, Inc. dba Berkeley Bionics and formerly dba Berkeley ExoWorks (“LICENSEE”), a Delaware corporation, having a principal place of business at 2131 University Avenue, #428, Berkeley, CA 94704. The parties agree as follows:
STOCK OPTION AGREEMENT EKSO BIONICS HOLDINGS, INC.Stock Option Agreement • January 23rd, 2014 • Ekso Bionics Holdings, Inc. • Wholesale-medical, dental & hospital equipment & supplies
LEAK-OUT AGREEMENTLeak-Out Agreement • April 5th, 2017 • Ekso Bionics Holdings, Inc. • General industrial machinery & equipment, nec
This agreement (the “Leak-Out Agreement”) is being delivered to you in connection with an understanding by and among Ekso Bionics Holdings, Inc., a Nevada corporation (the “Company”), and the person or persons named on the signature pages hereto (collectively, the “Holder”).